Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands

Leila Rostamizadeh, Ommoleila Molavi, Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond L. Lai
Journal
ISSN / E-ISSN
— / —
DOI
10.34172/bi.2022.23896 ↗
Volume · Issue · Pages
12 · 3 · 261-290
Publisher
Tabriz University of Medical Sciences
Article URL
https://doi.org/10.34172/bi.2022.23896 ↗
Article details
Unverified
Publication date (each date has its type and source)
26 Mar 2022
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date26 Mar 2022 OpenAlex

Keywords (as given): cancer immunotherapy; tumor microenvironment; immunosuppression; TLR agonists; cancer vaccines; TLR3 agonist; TLR4 agonist; TLR7 agonist; TLR9 agonist; immunomodulation

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for hjrs 2021-22 V2.
Journal
BioImpacts
Publication date used
26 Mar 2022 (OpenAlex publication date)
Applicable HEC period
hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
Category
X
Recognition status
Recognized (OK_RECORD_FOUND)
Source
hjrs-2021-22 row 11755
Verification status
Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.